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cough’'. Three weeks later, she progres­
sively developed a symmetrical eruption 
composed of 1-3 mm erythematous 
papules on the knees, ankles, elbows and 
forearms. She had mild fever and was 
quite miserable. Cervical and axillar lym- 
phadenopathy was present. Liver and 
spleen were enlarged, being 2 cm and 1 
cm respectively below the costal margins.
A clinical diagnosis of Gianotti-Crosti 
syndrome was made. Laboratory studies 
showed mild microcytic anaemia (Hb 11.8 
g/dl, MCV 75 p.3), lymphocytosis (leuco­
cytes 15 300/mm3 with 15% neutrophils, 
2.5% eosinophils, 1% basophils, 7.5% 
monocytes, 72.5 lymphocytes and 1,5% 
plasmocytes), and elevated liver enzymes
(AST 74 U/l, ALT 69 U/l). Seroconver­
sion to EBV was found with anti-viral 
capsid antigen IgM antibodies positive and 
anti-viral capsid antigen IgG titres raising 
from 1/40 to 1/320 in 2 months. Antibodies 
to human immunodeficiency virus 1-2, cy­
tomegalovirus, hepatitis A-B-C, parvovirus 
and toxoplasmosis remained negative. The 
child was unwell for 3 weeks and the erup­
tion then gradually disappeared over a 3- 
week period. No treatment was given.
Children may develop Gianotti-Crosti 
syndrome associated with EBV as the sole 
stimulatory factor, and it might well have 
been the case with this child. However, 
since Gianotti-Crosti syndrome can be 
considered the result of an individual im­
mune response to a viral infection and not 
the direct consequence of the virus itself, 
and since it has also been described after 
immunization, it is reasonable to think that 
in this child, both the immunization and the 
EBV infection acted as triggers to the erup­
tion. Such a sequence is in accordance with 
the recent suggestion that Gianotti-Crosti 
syndrome may need both a previous im­
mune stimulation and a viral infection [L].
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Sir: In the management of chronic and end 
stage renal failure the dietary intake of 
potassium and phosphate has to be re­
duced. Drugs that bind these compounds 
are prescribed on a large scale. These 
drugs have an unpleasant taste and have to 
be administered in relatively large vol­
umes. Pre-treatment of drinks with cal­
cium polystyrene-sulphonate leads to a 
50% reduction in potassium content [1,2]. 
The present study aims to reduce the phos­
phate content of milk, since this is the ma­
jor compound of infant nutrition. The 
method must be simple enough to be ap­
plied at home by the patient, and must not 
negatively influence the taste.
Five ml of normal cows milk were 
treated with calcium acetate (CaAe) in dif­
ferent quantities (15, 30, 45, 60, 75, and 
150 mg). Samples were mixed thoroughly, 
and stored for different periods (30, 60,
90, 120 min and 21 h) at two different 
temperatures (4°C and room temperature). 
After filtration at 4°C pH as well as cal­
cium, phosphate, and protein contents 
were measured.
Using this method no significant de­
crease in phosphate concentration was ob­
served, Table 1 shows the results of the 
addition of different quantities of CaAc on 
calcium and phosphate concentrations. 
Calcium concentration increased to 93 
mmol/1 with the highest CaAc addition.
Table 1 Effect of different amounts of 
CaAc on phosphate and calcium concentra­
tion in 5 ml of cows milk (4°C, 30 min)
Phosphate Calcium 
(mmoI/J) (mmol/1)
Untreated 30 32
15 mg CaAc 31 52
30 mg CaAc 27 61
45 mg CaAc 27 74
60 mg CaAc 28 87
75 mg CaAc 25 78
150 mg CaAc 28 93
Table 2 Influence of duration of incuba­
tion on calcium and phosphate concentra­
tion after the addition of 30 mg of CaAc, at 
two different temperatures. The first num­
ber gives the concentration at 4°C, the sec­
ond at room temperature
incubation
time
Phosphate
(mmol/1)
Calcium 
(mino 1/1)
30 m 30/30 66/64
60 m 27/30 60/63
90 m 35/34 72/56
120 m 29/29 63/63
21 h 31/31 65/64
pH and protein contents decreased 
markedly (from 6*71 to 6.05 and from 37 
to 29 g/i with 45 mg of CaAc). The milk 
developed an unpleasant sour taste if more 
than 30 mg of CaAc was added. The influ­
ence of duration of incubation and of tem­
perature is given in Table 2, using an 
amount of 30 mg of CaAc.
From these experiments it is clear that 
a simple precipitation reaction with CaAc 
is not a suitable method to reduce the 
phosphate content of milk. Other methods, 
such as dialysis may be applied, but these 
techniques are not suitable for routine do­
mestic use
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